ACTINIUM PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Payable
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Increase (Decrease) in Accounts Payable of -$6 for the 12-month period ending 2012-09-30, per its 10-Q filed 2012-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2012-11-14
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2012-09-30 was $2.21K, a 47.60% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2012-06-30 was -$1.00K.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2012-03-31 was $1.00K.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2011-12-31 was -$2.22K, a 248.00% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts payable for fiscal 2011 was -$13.69K, a 7266.49% decline from fiscal 2010.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts payable for fiscal 2010 was $191.00.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2012-09-30 | $2.21K derived: 10-Q 12 month − 3 quarters · filed 2012-11-14 | $1.21K derived: sum of 2 quarters · filed 2012-11-14 | $2.21K derived: sum of 3 quarters · filed 2012-11-14 | -$6.00 10-Q · filed 2012-11-14 |
| 2012-06-30 | -$1.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-29 | $0.00 10-Q/A · filed 2012-08-29 | -$2.22K derived: sum of 3 quarters · filed 2012-08-29 | -$720.00 derived: sum of 4 quarters · filed 2012-08-29 |
| 2012-03-31 | $1.00K 10-Q · filed 2012-04-23 | -$1.22K derived: sum of 2 quarters · filed 2012-04-23 | $280.00 derived: sum of 3 quarters · filed 2012-04-23 | |
| 2011-12-31 | -$2.22K 10-Q · filed 2012-04-23 | -$720.00 derived: sum of 2 quarters · filed 2012-04-23 | -$13.69K 10-K · filed 2012-04-12 | |
| 2011-09-30 | $1.50K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | -$12.19K 10-Q · filed 2011-11-14 | -$12.19K 10-Q · filed 2012-11-14 | |
| 2011-06-30 | -$13.69K 10-Q/A · filed 2012-08-29 | |||
| 2010-12-31 | $1.50K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-12 | $2.86K derived: sum of 2 quarters · filed 2012-04-12 | $191.00 10-K · filed 2012-04-12 | |
| 2010-09-30 | $1.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$1.31K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | -$2.67K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |